EUVIMEDEUVIMED entdecken
Open Access

Analysis of long-term outcomes and exceptional responders after non-curative thoracic (chemo)radiotherapy for stage II/III non-small cell lung cancer

Carsten Nieder, Siv Gyda Aanes, Luka Stanisavljevic, Bård Mannsåker

Reports of Practical Oncology and Radiotherapy · 12.06.2026

DOI: 10.5603/rpor.113086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reports of Practical Oncology and Radiotherapy, online erschienen am 12.06.2026. Verfasst von Carsten Nieder und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chemoradiationdisease controlindividualised radiotherapylung cancerprognostic factorsradiation treatmentresponders

Autor:innen und Institutionen

  • Department of Oncology and Palliative Medicine, Nordland Hospital, Bodø, Norway.
  • Department of Clinical Medicine, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.

Zitieren

APA

Nieder, C., Aanes, S. G., Stanisavljevic, L., & Mannsåker, B. (2026). Analysis of long-term outcomes and exceptional responders after non-curative thoracic (chemo)radiotherapy for stage II/III non-small cell lung cancer. Reports of Practical Oncology and Radiotherapy. https://doi.org/10.5603/rpor.113086

Vancouver

Nieder C, Aanes SG, Stanisavljevic L, Mannsåker B. Analysis of long-term outcomes and exceptional responders after non-curative thoracic (chemo)radiotherapy for stage II/III non-small cell lung cancer. Reports of Practical Oncology and Radiotherapy. 2026. doi:10.5603/rpor.113086

BibTeX
@article{Nieder2026,
  author = {Nieder, Carsten and Aanes, Siv Gyda and Stanisavljevic, Luka and Mannsåker, Bård},
  title = {Analysis of long-term outcomes and exceptional responders after non-curative thoracic (chemo)radiotherapy for stage II/III non-small cell lung cancer},
  journal = {Reports of Practical Oncology and Radiotherapy},
  year = {2026},
  doi = {10.5603/rpor.113086}
}
Kostenlos starten →